Results 151 to 160 of about 9,903 (207)

Repurposing of the bisbenzimide antibiotic Ridinilazole as an antiviral compound against human cytomegalovirus. [PDF]

J Gen Virol
Pinto H, Latham KA, Goodbourn S, Witney AA, Strang BL.   +4 more
europepmc   +1 more source

CMV infections after HSCT: prophylaxis and treatment. [PDF]

Blood Res
Chung H.
europepmc   +1 more source

Varicella-Zoster Virus Infection and Varicella-Zoster Virus Vaccine-Related Ocular Complications. [PDF]

Vaccines (Basel)
Yu J, Li H, Ji Y, Liao H.
europepmc   +1 more source

Recent advances in human cytomegalovirus: a comprehensive review of pathogenic mechanisms, virus-host interactions, and antiviral strategies. [PDF]

Front Immunol
Xia Y, Zhang J, Shui X, Wang C, Zhang S, Chai W, Yang Y, Shen L, Wang C.   +8 more
europepmc   +1 more source

Novel cytomegalovirus variants in immunocompromised hosts: genetic insights and clinical significance. [PDF]

Front Microbiol
Alsweed AM, Alsanea MS, Almaghrabi RS, Al-Qahtani AA, AlSuhaibani M, Alhajjar SH, Alhamlan FS.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Foscarnet Sodium

Retina, 1991
Cytomegalovirus (CMV), a major opportunistic viral pathogen frequently causing disease in immunocompromised patients such as organ transplant recipients and people with AIDS, may present as pneumonitis, gastrointestinal disease, or encephalitis. Its most common manifestation in patients with AIDS is retinitis which, if left untreated, invariably ...
J R, Minor, J K, Baltz
openaire   +2 more sources

Foscarnet

Reactions Weekly, 1993
  +6 more sources

Foscarnet

Reactions Weekly, 2023
Helga Peter, Thomas Penzel
openaire   +2 more sources